Aquestive Therapeutics, Inc. (AQST)
4.17
-0.56
(-11.84%)
USD |
NASDAQ |
May 15, 16:00
4.24
+0.07
(+1.68%)
After-Hours: 20:00
Aquestive Therapeutics Research and Development Expense (Quarterly) : 4.204M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Nektar Therapeutics | 35.68M |
| Crinetics Pharmaceuticals, Inc. | 98.92M |
| Harrow, Inc. | 5.895M |
| MariMed, Inc. | -- |
| Journey Medical Corp. | 0.00 |